MO BIO Laboratories, Inc. Launches the RTS DNase™ Kit

CARLSBAD, Calif. -- MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of the RTS DNase™ Kit, which includes the first room temperature stable DNase I enzyme. The RTS DNase™ Kit efficiently removes contaminating genomic DNA from RNA preparations while protecting valuable RNA samples from damage during [...]

Fluxion Biosciences Announces Early Access Program for IsoFlux™ Rare Cell Access System

SOUTH SAN FRANCISCO, Calif.--Fluxion Biosciences, Inc. announced today that it has launched an Early Access Program for its IsoFlux Rare Cell Access System. The program will enable scientists to incorporate circulating tumor cells (CTC) and other rare cell assays into their research prior to the IsoFlux commercial product release. Circulating tumor cells disseminate from primary [...]

Minoru Sakakibara is the new President and CEO of American Peptide Company

Sunnyvale, CA - American Peptide Company, a leading provider of peptides and peptide conjugates to the pharmaceutical and life science industries, announced today the appointment of Minoru Sakakibara as the new President and CEO of the company. Mr. Sakakibara’s predecessor, Takahiro Ogata, has been promoted to CEO of ILS Inc., the parent company of American [...]

Analytik Jena AG provides active support in repairing the earthquake damage in Japan

Jena — Analytik Jena AG has delivered two high quality analysis measuring instruments to a health facility in the Japanese province Miyagi and installed them on site. The Public Health Society in the provincial capital of Sendai in Northeast Japan will benefit from the donation of the device. Similar to the neighboring region Fukushima, the [...]

Cellular Dynamics Announces Commercial Launch of iCell® Endothelial Cells for Vascular-targeted Drug Discovery

MADISON, Wis. – Cellular Dynamics International (CDI) today announced the commercial launch of human iCell® Endothelial Cells for use in vascular-targeted drug discovery, tissue regeneration and other life science research. Endothelial cells make up the lining of blood vessels and thus are an important factor of vascular research across a multitude of disease states. Endothelial [...]

Ingenuity Announces New Additional MicroRNA Content to Complement First-of-its-Kind MicroRNA Filtering Capability in IPA

REDWOOD CITY, Calif. – Ingenuity® Systems, a leading provider of information and analytics solutions for life science researchers, today announced the addition of new experimentally validated microRNA-mRNA target interactions from miRecords, plus thousands of additional miRNA-mRNA interactions manually curated from additional peer-reviewed literature. The newly added content supplements existing experimentally demonstrated and predicted miRNA targets [...]

SAW Instruments Launches New sam®X Acoustic Biosensor at MipTec 2011

Basel, Switzerland – SAW Instruments GmbH, developer of innovative biosensor technology for life sciences research in biotech and academia, has launched the sam®X acoustic biosensor in Europe at MipTec, Basel, Switzerland (20-22 September). sam®X is the latest high-end addition to the sam® range of acoustic biosensors, featuring eight analysis channels and adaptable routing that expands [...]

Microsoft Launches the Chemical Reference Architecture Initiative

REDMOND, Wash. -- Microsoft Corp. today launched the Microsoft Chemical Reference Architecture (ChemRA) Initiative, an effort led by Microsoft to develop, along with its partners that provide solutions to the chemical and oil refining industries, a reference architecture framework that will help address business and technological needs for customers in the industry. ChemRA will benefit [...]

Attana AB and Layerlab AB sign global distribution agreement

Stockholm, Sweden - memLAYER™, one of Layerlab’s core products, is a chemistry kit that provides biosensor users with a unique approach of immobilizing biological membranes to biosensor surfaces. This enables easier analysis of membrane protein functionality, saving both time and money in the process of drug development. “Attana is continually striving for collaborations that lead [...]

Simulations Plus Submits Bid in Chapter 11 Bankruptcy Proceedings for Assets of Entelos

LANCASTER, Calif.-- Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has submitted a bid to purchase substantially all of the assets of Entelos, Inc., in an auction supervised by and in accordance with certain bidding procedures approved by the United States Bankruptcy Court [...]

Access IBO on Knowledge Center